Upload
aniki
View
213
Download
0
Embed Size (px)
Citation preview
CLINICAL INVESTIGATION
Infectious causes of posterior uveitis and panuveitis in Thailand
Natedao Kongyai • Kessara Pathanapitoon •
Wasna Sirirungsi • Paradee Kunavisarut •
Jolanda D. F. de Groot-Mijnes • Aniki Rothova
Received: 2 November 2011 / Accepted: 26 March 2012 / Published online: 28 April 2012
� Japanese Ophthalmological Society 2012
Abstract
Purpose To determine the infectious causes of posterior
uveitis (PU) and panuveitis (panU) in Thailand.
Methods We investigated the infectious causes of uveitis
involving the posterior segment of the eye by using real-time
polymerase chain reaction (PCR) for cytomegalovirus (CMV),
herpes simplex virus (HSV-1, HSV-2), varicella zoster virus
and Toxoplasma gondii (T. gondii) DNA in intraocular sam-
ples of 80 human immunodeficiency virus (HIV)-negative
patients. Additionally, in 61 patients, we performed Gold-
mann–Witmer coefficient (GWC) analysis for T. gondii.
Results Twenty-four (30 %) patients with PU and/or
panU had a positive PCR result. Overall, CMV was the
most frequently identified organism. While CMV was the
most common cause of uveitis in the patients on immu-
nosuppressive medications for nonocular disorders, HSV
was the most common cause of posterior and panuveitis in
the patients not receiving such medication. In 38 PU
patients, CMV was the most common detected pathogen.
In 42 panU patients, CMV and HSV-2 were the most fre-
quently identified pathogens. Out of 61 paired samples
analyzed for T. gondii by GWC analysis, only 1 revealed a
positive result. There was no difference in PCR results
between aqueous humor and vitreous samples.
Conclusions CMV was the most frequently identified
infectious organism in posterior and panuveitis of HIV-1-
negative Thai patients. Aqueous humor and vitreous sam-
ples showed similar diagnostic values in PCR analysis.
Keywords Posterior uveitis � Panuveitis � Polymerase
chain reaction � Intraocular fluids � Thailand
Introduction
The etiological spectrum of infectious uveitis differs
throughout the world because of various factors, including
geographic and demographic influences [1–3]. In Western
countries, the most frequent anatomical type of uveitis is
anterior uveitis (AU), whereas in Africa, Asia and South
America, the involvement of the posterior eye segment is
more common [1–3]. Uveitis located in the posterior eye
segment is usually severe and frequently associated with
infections, while the majority of anterior uveitis cases are
temporary, frequently mild and of non-infectious origins.
Early detection of infection is important because specific
antibiotic treatment can be employed for patients with
infections, whereas non-infectious uveitis is usually treated
with immunosuppressive drugs.
Herpes viruses and Toxoplasma gondii (T. gondii) rep-
resent the most common causes of infectious posterior
N. Kongyai � W. Sirirungsi
Department of Medical Technology, Faculty of Associated
Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
K. Pathanapitoon (&) � P. Kunavisarut
Department of Ophthalmology, Faculty of Medicine,
Chiang Mai University, 110 Intawaroros Road,
Chiang Mai 50200, Thailand
e-mail: [email protected]
J. D. F. de Groot-Mijnes
Department of Virology, University Medical Center Utrecht,
Utrecht, The Netherlands
J. D. F. de Groot-Mijnes � A. Rothova
Department of Ophthalmology, University Medical Center
Utrecht, Utrecht, The Netherlands
A. Rothova
Department of Ophthalmology, Erasmus Medical Center,
Rotterdam, The Netherlands
123
Jpn J Ophthalmol (2012) 56:390–395
DOI 10.1007/s10384-012-0144-5
uveitis (PU) in Western countries, but a different spectrum
of infections might be encountered in other geographical
areas [1–3]. Although T. gondii and herpetic infections
were recognized as the major causes of infectious posterior
and panuveitis (PU) in Asian populations, in those studies,
the specific diagnoses were based mainly on clinical
grounds, sometimes in combination with laboratory blood
analysis and imaging studies of the chest [2–4].
We investigated the infectious causes of uveitis
involving the posterior segment of the eye by analyzing the
intraocular fluids using real-time polymerase chain reaction
(PCR). In addition, we assessed the diagnostic values of
aqueous humor and vitreous humor samples.
Materials and methods
Eighty intraocular fluid samples from 80 consecutive
patients with PU (n = 38) and panU (n = 42) of unknown
origin and negative results in the uveitis screening protocol
(see below) were collected at the Department of Ophthal-
mology, Chiang Mai University Hospital from 2005 to
2010. Uveitis classification was performed according to the
anatomic localization recommended by the SUN working
group [5]. All patients tested negative for human immu-
nodeficiency virus type 1 (HIV-1). We attempted to collect
the samples in a systematic manner without inclusion bias.
Aqueous sampling was carried out as a second diagnostic
step in patients with negative initial screening, which
included chest X-rays and various laboratory tests,
including erythrocyte sedimentation rates, complete blood
counts and serology for Treponema pallidum. When
appropriate, the tuberculin skin test and serology for
T. gondii were also administered. Intraocular fluid samples
and paired plasma were collected from the patients
approximately within 1 or 2 weeks after the presentation.
Vitreous collection was principally performed as a third
diagnostic step, with the exception of those patients with
retinal detachment or extremely severe vitritis where
therapeutically pars plana vitrectomy (PPV) was required
and vitreous samples could be collected during surgery
without previous aqueous humor acquisition.
Ten out of the 80 patients received immunosuppressive
medications for systemic diseases or organ transplants.
This study was performed with the approval of the local
medical ethics committee and complied with the tenets of
the Declaration of Helsinki.
Intraocular fluid specimens included 54 aqueous humor
and 26 vitreous humor samples. All samples were stored at
-70 �C until laboratory analyses. The laboratory investi-
gations were performed at the Division of Clinical
Microbiology, Department of Medical Technology, Faculty
of Associated Medical Sciences, Chiang Mai University,
Chiang Mai, Thailand. All 80 intraocular fluid samples
were analyzed for cytomegalovirus (CMV), herpes simplex
virus-1 (HSV-1), herpes simplex virus-2 (HSV-2), vari-
cellar zoster virus (VZV) and T. gondii DNA by real-time
PCR.
Real-time PCR analysis was performed as follows.
Nucleic acid was extracted from 25 ll of intraocular fluid
using the QIAamp� DNA Blood Mini Kit (QIAGEN, Inc.,
Germantown, MD, USA). Before extraction, 2,500–5,000
copies/ml of phocid herpes virus type 1 (PhHV-1) were
added to each sample to monitor the quality of extraction
and the amplification procedures [6]. Each focal pathogenic
DNA was separately analyzed by real-time PCR with a
repeated cycling program as previously described [7, 8].
Briefly, 10 ll of the extracted nucleic acid was added to
15 ll of the real-time PCR mixture (DyNAmoTM Probe
qPCR kit, New England Biolabs Inc., Keilaranta, Espoo,
Finland), which contained specific primers and probes.
Then, real-time PCR was performed in a Chromo4TM-Real-
time PCR Detector Machine (DNA Engine�, Bio-Rad,
Hercules, CA, USA) [8].
In addition, in 61 out of the 80 patients, paired plasma
and intraocular samples were tested for active intraocular
production of a specific antibody against T. gondii
by Goldmann–Witmer coefficient (GWC) analysis. The
amount of specific immunoglobulin G (IgG) against
T. gondii in plasma and intraocular fluid was determined by
Sirion� ELISA classic Toxoplasma gondii IgG kits (Serion
Immunodiagnostica GmbH, Wurzburg, Germany). The
assay was performed according to the manufacturer’s
instructions. Total IgG concentrations were measured by an
in-house ELISA using commercially available reagents.
For the total IgG concentration determination, seven serial
two-fold dilutions of a nephelometer N Protein standard SL
(Dade Behring, Siemens Healthcare Diagnostics, Products
GmbH, Marburg, Germany) were included. A GWC value
equal to or greater than 3 was considered positive and
indicative of active intraocular antibody production [7].
For statistical analysis, we used Fisher’s exact test and
Pearson’s Chi-square test to compare the diagnostic values
of the aqueous humor and vitreous humor analysis. P val-
ues below 0.05 were considered significant. All statistical
calculations were performed using STATATM 10.1 soft-
ware (Statacorp, College Station, TX, USA).
Results
The average age of the patients was 42 years (range
6–67 years), and the male-to-female ratio was 1:1.2.
The results of the PhHV-1 internal control real-time
PCR implied successful nucleic acid extraction and no
inhibition of the amplification reactions in all the samples.
Infectious causes of posterior uveitis 391
123
Positive PCR results for any of the investigated agents
were found in 24/80 (30 %) patients. CMV was the most
frequently detected pathogen (12/80; 15 % of all and
12/24; 50 % of those with a positive PCR). HSV-1, HSV-2,
VZV and T. gondii were found in similar low percentages
(3–10 %, Table 1).
The infectious causes of PU and panU were similar;
however, HSV-2 and VZV were detected solely in panU
(Table 1). CMV was the most common cause of PU
(21 %), followed by HSV-1 and T. gondii. In panU, CMV
and HSV-2 were most commonly detected (both 10 %). All
10 patients receiving immunosuppressive medications were
positive for CMV in PCR, while only 2/70 patients who did
not received immunosuppressive agents had a positive PCR
result for CMV (P \ 0.001). In patients without immuno-
suppressive medications, HSV was the most common
cause of uveitis located in the posterior eye segment (7 out
of 70, 10 %).
In addition to PCR, GWC analysis for T. gondii revealed
a positive result in 1/61 patients (1.6 %, Table 2). This
patient was a 55-year-old woman with unilateral panuveitis
and focal retinitis, a negative result for PCR and positive
GWC result (5.28).
A comparison between aqueous humor and vitreous
humor PCR results is given in Table 3. Aqueous humor
samples exhibited positive PCR results in 19/54 (35 %)
and vitreous humor samples in 5/26 (19 %) (P = 0.145;
Pearson Chi-square analysis; Table 3). VZV (n = 2) and
T. gondii (n = 3) were detected solely in the aqueous
humor samples. When PU and panU were compared, no
differences were observed in either the aqueous humor or
the vitreous humor.
Clinical features of patients are given in Table 4. Ten
out of 12 (83 %) CMV-positive patients were considered
partially immunosuppressed because of immunosuppres-
sive drugs (in contrast to 0/12 patients positive for the other
investigated infection agents, P \ 0.001, and to 3/56
patients of undetermined etiology, P \ 0.001, Fisher’s
exact test). Clinical features of HSV-1 infection included
focal retinitis, vitritis and tractional retinal detachment.
Three out of 4 patients with HSV-2 infection were younger
than 30 years, and all had clinical characteristics of acute
retinal necrosis (extensive necrotic peripheral retinitis with
hemorrhages).
Four patients were diagnosed with ocular toxoplasmo-
sis: three with real-time PCR and one additional patient
with GWC, but none of these had positive results in both
examinations. Three patients had focal retinitis and one
had retinal vasculitis without any focal retinal lesions
detectable.
Our study included 10 patients with focal retinitis of
unknown origin who were negative in real-time PCR (10/
10) and GWC (8/8) for T. gondii. Toxoplasma serology
was negative in 2 out of 7 tested.
Acute retinal necrosis (ARN) was diagnosed clinically
in 9 patients, of whom 4 were associated with positive PCR
results for CMV, 3 for HSV-2 and 1 for VZV.
Discussion
In our study, CMV was identified as the most common
infectious entity in HIV-negative patients with PU and
panU (12/80; 15 %). High percentages of CMV infections
in our posterior and/or panuveitis patients differ from a
previous study in which the main culprit was Toxoplasma
gondii [9]. Reports on CMV-associated posterior or pan-
uveitis in HIV-negative patients are limited and usually
described in post-transplant patients with severe immuno-
suppression [10–13]. In our series, the use of immuno-
suppressive drugs played a definite role in the development
of CMV-associated PU and panU as these medications
were being used in 83 % of our CMV-positive patients.
HSV was the most common cause of both the posterior and
panuveitis in those patients not receiving immunosup-
pressive medications.
The small number of ocular toxoplasmosis cases (5 %) in
our series is distinct from the West, where ocular
Table 1 Detection of infectious agents by real-time PCR in intra-
ocular fluids of posterior uveitis and panuveitis patients
Infectious
agents
Positive results of real-time PCR (%)
Posterior uveitis
(N = 38)
Panuveitis
(N = 42)
Total
(N = 80)
CMV 8 (21 %) 4 (10 %) 12 (15 %)
HSV-1 2 (5 %) 1 (2 %) 3 (4 %)
HSV-2 0 (0 %) 4 (10 %) 4 (5 %)
VZV 0 (0 %) 2 (5 %) 2 (3 %)
T. gondii 2 (5 %) 1 (2 %) 3 (4 %)
Total 12 (31 %) 12 (29 %) 24 (30 %)
PCR, polymerase chain reaction; CMV, cytomegalovirus; HSV-1,
herpes simplex virus type 1; HSV-2, herpes simplex virus type 2;
VZV, varicella zoster virus; T. gondii, Toxoplasma gondii
Table 2 Detection of Toxoplasma gondii by Goldmann–Witmer
coefficient in intraocular fluids of posterior uveitis and panuveitis
patients
Infectious
agents
Positive results of Goldmann–Witmer coefficient (%)
Posterior
uveitis
(N = 31)
Panuveitis
(N = 30)
Total (posterior and
panuveitis) (N = 61)
Toxoplasmagondii
0 (0 %) 1 (3.3 %) 1 (1.6 %)
392 N. Kongyai et al.
123
toxoplasmosis represents a major cause of posterior segment
inflammations [14, 15]. Absence of ocular toxoplasmosis
was noted in China as well [16]. Causes for these regional
differences are unknown; various factors such as diet,
hygiene, infection of the environment by cysts and differ-
ences in pathogenicity of the regional strains might all be
involved. In addition, the age in which seroconversion and
parasitemia takes place might also play a role. Seropreva-
lence for T. gondii in Thailand was 17 % [17], comparable
to China (14.8 %) [18] and India (24 %) [19], but lower than
in Indonesia (58–70 %) [20, 21] and higher than in Vietnam
(4.2 %) [22]. When compared to the West, seroprevalence
for T. gondii in Thailand was lower than in the Netherlands
(41 %) and France (75 %), but similar to the US
(14–22.5 %) where T. gondii infections represent the most
common cause of intraocular infections in PU [1, 23]. Fur-
ther research is required to clarify these discrepancies.
Herpetic infectious uveitis is reported in many previous
studies. The prevalence of herpetic uveitis among PU and
panU patients varies between 0.6 and 4 % [4, 24–27].
Herpetic infections in the posterior eye segment are pre-
dominantly associated with clinical features of ARN
[28, 29]. In our study, the prevalence of positive PCR
results for HSV and VZV was lower than in Europe [7]. All
4 patients with ARN were positive for either HSV or VZV;
however, similar to previous reports, these viruses were
also identified in the patients with non-ARN panuveitis and
with vasculitis [30, 31].
So far, there is no agreement on which specimens
(aqueous humor or vitreous humor) should be examined for
the detection of infectious agents in posterior segment
uveitis. Until now, a systematic comparison of the diag-
nostic values of the aqueous humor and vitreous humor
samples in posterior uveitis has not been available. In the US,
analysis of the vitreous humor is recommended in patients
with atypical or severe uveitis because it renders a sufficient
volume of specimens for multiple examinations [32, 33].
However, both vitreous tapping and vitrectomy are invasive
Table 3 Comparison of aqueous humor and vitreous humor analysis by real-time PCR in posterior and panuveitis patients
Infectious
agent
Intraocular fluid samples (N = 80) P value; Pearson’s
Chi-square test (aqueous
humor versus vitreous humor)Aqueous humor
(N = 54)
Vitreous humor
(N = 26)
CMV 9 (17 %) 3 (12 %) 0.547
HSV-1 2 (4 %) 1 (4 %) 0.975
HSV-2 3 (6 %) 1 (4 %) 0.742
VZV 2 (4 %) 0 0.320
T. gondii 3 (6 %) 0 0.221
Total 19 (35 %) 5 (19 %) 0.145
PCR, polymerase chain reaction; CMV, cytomegalovirus; HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex virus type 2; VZV,
varicella zoster virus; T. gondii, Toxoplasma gondii
Table 4 Clinical manifestations of patients with posterior uveitis and panuveitis, and results of real-time PCR analysis
Positive PCR result N (80) Male-to-
female
ratio
Average
age
(years)
Focal
retinitis
ARN
features
Choroiditis Retinal
vasculitis
Retinal detachment Optic
neuritis
CMV 12 6:6 46 3 4 0 3 Tractional, n = 1 0
HSV-1 3 2:1 43 1 0 0 0 Tractional, n = 1 0
HSV-2 4 2:2 29 1 3 0 0 Rhegmatogenous, n = 1 1
VZV 2 0:2 49 1 1 0 0 0 0
T. gondii 3 3:0 44 3 0 0 1 0 0
Total patients with
positive PCR
results
24 13:11 43 9 8 0 4 Tractional, n = 2
rhegmatogenous, n = 1
1
PCR-negative
intraocular fluid
analysis
56 24:32 40 10 1 4 9 Tractional, n = 4 exudative,
n = 5 rhegmatogenous,
n = 1
7
PCR, polymerase chain reaction; CMV, cytomegalovirus; HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex virus type 2; VZV,
varicella zoster virus; T. gondii, Toxoplasma gondii; ARN, acute retinal necrosis
Infectious causes of posterior uveitis 393
123
procedures with potential adverse effects, limited accessi-
bility and high costs [32, 33], whereas aqueous humor sam-
pling can be performed conveniently even in an outpatient
setting and is reported to be safe in the hands of an experi-
enced ophthalmologist [34]. Tests performed with aqueous
humor samples showed high diagnostic values, even in
patients with uveitis located in the posterior segment [9, 35,
36]. Our findings on positive results from aqueous humor
samples are in accordance with previous reports on the
diagnostic value of aqueous humor analysis in posterior
uveitis [9, 35, 36]. In our study the aqueous humor and the
vitreous humor samples had similar diagnostic values.
It is reported that the diagnostic efficacy of aqueous humor
analysis can be improved with the concurrent use of GWC
and PCR [7, 37]. Errera et al. recently reported the sensitivity
and specificity of real-time PCR and GWC in intraocular
samples of posterior uveitis patients’ collected at different
time points during the clinical course. GWC showed higher
diagnostic values for T. gondii detection, especially when the
test was carried out late in the disease course [37]. However,
in our study, GWC for T. gondii was found positive in one
patient only. The higher prevalence of positive PCR in ocular
toxoplasmosis in our series could be explained in part by a
severe inflammation encountered in our patients.
There are several limitations to our study, including the
fact that, like in other series from tertiary centers, sampling
of material for intraocular analysis was performed with a
strong selection bias. Obviously, less severe cases with
clinically easily recognized uveitis entities would not be
sampled. Our results are based on only five tested patho-
gens, which implies that other infections were not con-
sidered. The sensitivity of real-time PCR, the immune
status of the patient and the timing of specimen collection
during the course of disease might also have affected the
results since specific antibodies and genomes of pathogens
are present in the plasma and intraocular fluid at different
times during infection.
Despite these limitations, our findings provide an insight
into the causative agents of infectious posterior uveitis and
panuveitis in HIV-1-negative Thai patients and further
reveal that an analysis of the aqueous is highly informative
for inflammations of the posterior eye segment.
Conclusions
CMV infection represents the most frequently identified
infectious organism in posterior and panuveitis in HIV-
negative patients in Thailand. PCR examinations of the
aqueous humor and vitreous humor samples exhibited
similar diagnostic values.
References
1. Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol
Clin. 2005;45:1–13.
2. Rathinam SR, Namperumalsamy P. Global variation and pattern
changes in epidemiology of uveitis. Indian J Ophthalmol.
2007;55:173–83.
3. London NJ, Rathinam SR, Cunningham ET Jr. The epidemiology
of uveitis in developing countries. Int Ophthalmol Clin.
2010;50:1–17.
4. Pathanapitoon K, Kunavisarut P, Ausayakhun S, Sirirungsi W,
Rothova A. Uveitis in a tertiary ophthalmology centre in Thai-
land. Br J Ophthalmol. 2008;92:474–8.
5. Standardization of uveitis nomenclature (SUN) working group.
Standardization of uveitis nomenclature for reporting clinical
data. Results of the first international workshop. Am J Ophthal-
mol. 2005;140:509–16.
6. Niesters HG. Standardization and quality control in molecular
diagnostics. Expert Rev Mol Diagn. 2001;1:129–31.
7. de Groot-Mijnes JDF, Rothova A, van Loon AM, Schuller M, ten
Dam-Van Loon NH, de Boer JH, et al. Polymerase chain reaction and
Goldmann–Witmer coefficient analysis are complimentary for the
diagnosis of infectious uveitis. Am J Ophthalmol. 2006;141:313–8.
8. Pathanapitoon K, Kongyai N, Sirirungsi W, de Groot-Mijnes JD,
Leechanachai P, Choovuthayakorn J, et al. The diagnostic value
of intraocular fluid analysis by polymerase chain reaction in Thai
patients with uveitis. Trans R Soc Trop Med Hyg. 2011;105:
650–4.
9. Rothova A, de Boer JH, ten Dam-van Loon NH, Postma G, de
Visser L, Zuurveen SJ, et al. Usefulness of aqueous humor
analysis for the diagnosis of posterior uveitis. Ophthalmology.
2008;115:306–11.
10. Xhaard A, Robin M, Scieux C, de Latour RP, Deplus S, Mazeron
MC, et al. Increased incidence of cytomegalovirus retinitis after
allogeneic hematopoietic stem cell transplantation. Transplanta-
tion. 2007;83:80–3.
11. Chung H, Kim Kh, Kim Jg, Lee SY, Yoon YH. Retinal com-
plications in patients with solid organ or bone marrow trans-
plantations. Transplantation. 2007;83:694–9.
12. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features
and outcomes of cytomegalovirus retinitis after transplantation.
Transpl Infect Dis. 2008;10:13–8.
13. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N,
Al-Sharif F. Ocular findings after allogeneic hematopoietic stem
cell transplantation. Ophthalmology. 2009;116:1624–9.
14. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort R,
O’Connor GR. Intraocular inflammatory reactions without focal
necrotizing retinochoroiditis in patients with acquired systemic
toxoplasmosis. Am J Ophthalmol. 1999;128:413–20.
15. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin
Ophthalmol. 2003;14:384–8.
16. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical
patterns and characteristics of uveitis in a tertiary center for
uveitis in China. Curr Eye Res. 2005;30:943–8.
17. Sirirungsi W, Pathanapitoon K, Kongyai N, Weersink A, de
Groot-Mijnes JDF, Leechanachai P, et al. Infectious uveitis in
Thailand: serologic analyses and clinical feature. Ocul Immunol
Inflamm. 2009;17:17–22.
18. Li S, Cui L, Zhao J, Dai P, Zong S, Zuo W, et al. Seroprevalence
of Toxoplasma gondii infection in female sterility patients in
China. J Parasitol. 2011;97:529–30.
19. Dhumne M, Sengupta C, Kadival G, Rathinaswamy A, Velumani
A. National seroprevalence of Toxoplasma gondii in India.
J Parasitol. 2007;93:1520–1.
394 N. Kongyai et al.
123
20. Konishi E, Houki Y, Harano K, Mibawani RS, Marsudi D, Ali-
basah S, et al. High prevalence of antibody to Toxoplasma gondiiamong humans in Surabaya, Indonesia. Jpn J Infect Dis.
2000;53:238–41.
21. Terazawa A, Muljono R, Susanto L, Margono SS, Konishi E.
High Toxoplasma antibody prevalence among inhabitants in
Jakarta, Indonesia. Jpn J Infect Dis. 2003;56:107–9.
22. Udonsom R, Lekkla A, Chung PT, Cam PD, Sukthana Y. Sero-
prevalence of Toxoplasma gondii antibody in Vietnamese vil-
lagers. Southeast Asian J Trop Med Public Health. 2008;39:14–8.
23. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I:
epidemiology and course of disease. Am J Ophthalmol. 2003;
136:973–88.
24. Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C,
Papo T, et al. Chronic severe uveitis: etiology and visual outcome
in 927 patients from a single center. Medicine (Baltimore).
2001;80:263–70.
25. Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye
clinic in north India. Indian J Ophthalmol. 2004;52:121–5.
26. Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S.
Epidemiological survey of intraocular inflammation in Japan. Jpn
J Ophthalmol. 2007;51:41–4.
27. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A,
Alberts C, et al. Uveitis and systemic disease. Br J Ophthalmol.
1992;76:137–41.
28. Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP.
Viral causes of the acute retinal necrosis syndrome. Am J Oph-
thalmol. 2000;129:166–72.
29. Van Gelder RN, Willig JL, Holland GN, Kaplan HJ. Herpes
simplex virus type 2 as a cause of acute retinal necrosis syndrome
in young patients. Ophthalmology. 2001;108:869–76.
30. Bodaghi B, Rozenberg F, Cassoux N, Fardeau C, LeHoang P.
Nonnecrotizing herpetic retinopathies masquerading as severe
posterior uveitis. Ophthalmology. 2003;110:1737–43.
31. Wensing B, de Groot-Mijnes JD, Rothova A. Necrotizing and
nonnecrotizing variants of herpetic uveitis with posterior segment
involvement. Arch Ophthalmol. 2011;129:403–8.
32. Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy
specimens. Am J Ophthalmol. 2005;140:822–9.
33. Mruthyunjaya P, Jumper JM, McCallum R, Patel DJ, Cox TA,
Jaffe GJ. Diagnostic yield of vitrectomy in eyes with suspected
posterior segment infection or malignancy. Ophthalmology.
2002;109:1123–9.
34. Van der Lelij A, Rothova A. Diagnostic anterior chamber para-
centesis in uveitis: a safe procedure? Br J Ophthalmol. 1997;81:
976–9.
35. van Gelder RN. CME review: polymerase chain reaction diag-
nostics for posterior segment disease. Retina. 2003;23:445–52.
36. Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain
reaction analysis of aqueous and vitreous specimens in the
diagnosis of posterior segment of infectious uveitis. Am J Oph-
thalmol. 2009;147:140–7.
37. Errera MH, Goldschmidt P, Batellier L, Degorge S, Heron E,
Laroche L, et al. Real-time polymerase chain reaction and
intraocular antibody production for diagnosis of viral versus
toxoplasmic infectious posterior uveitis. Graefes Arch Clin Exp
Ophthalmol. 2011;249:1837–46.
Infectious causes of posterior uveitis 395
123